|Articles|May 7, 2019
RPG and WuXi CDS Rebrand as WuXi Clinical
Advertisement
Research Point Global and WuXi Clinical Development Services have announced that they will rebrand as WuXi Clinical at DIA 2019 in San Diego, CA. The newly combined CRO specializes in collaborative partnering for global clinical trials, and prides itself in its extremely patient-centric approaches.
For mor informaton click
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Novo Nordisk’s Phase III OASIS 4 Analyses Highlight Cardiometabolic Benefits of Oral Semaglutide 25 mg
2
Eli Lilly’s Phase II Trial of Eloralintide Shows Up to 20% Weight Reduction in Adults With Obesity
3
FDA Approves Caplyta as Adjunctive Therapy for Major Depressive Disorder Based on Positive Phase III Results
4
Using AI and Tokenized Data to Match Patients to Protocols
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
